Stay updated on rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA revision tag on the page has been updated from v3.5.3 to v3.5.4, signaling a newer version of the page's documentation. This change does not modify the trial information or other substantive content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe Sweden site entry now uses the correct Malmö spelling (with the umlaut) instead of Malmo, reflecting a location update in the study's site list.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page’s footer “Revision” label was updated from v3.5.2 to v3.5.3, reflecting a background website version update rather than any change to the clinical trial content.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Idiopathic Pulmonary Fibrosis and a Genetic and Rare Diseases Information Center resources link; updated revision from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check61 days agoChange Detected- Updated the Veneto, Italy location from Padua to Padova (Padova, Veneto, Italy, 35128) in the study locations.SummaryDifference0.0%

- Check68 days agoChange DetectedRemoved the 'Interstitial lung disease 2' tag and the Genetic and Rare Diseases Information Center resource; these elements are ancillary navigation and external information rather than core trial details.SummaryDifference0.0%

Stay in the know with updates to rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.